Provided By GlobeNewswire
Last update: Aug 30, 2023
ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Overland Park Regional Medical Center (OPRMC) launched and successfully completed the first procedures using the advanced Genesis Robotic Magnetic Navigation (RMN) System.
NYSEARCA:STXS (5/9/2025, 10:59:28 AM)
2.19
+0.03 (+1.39%)
Find more stocks in the Stock Screener